{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:00:07Z","timestamp":1788044407105,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12185-023-03695-8","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T06:02:25Z","timestamp":1706680945000},"page":"338-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Histiocytic sarcoma following CAR T-cell therapy: a case report"],"prefix":"10.1007","volume":"119","author":[{"given":"Kang","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benshang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"issue":"9","key":"3695_CR1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1200\/JCO.22.01214","volume":"41","author":"T Wang","year":"2023","unstructured":"Wang T, Tang Y, Cai J, et al. Coadministration of CD19- and CD22-directed chimeric antigen receptor T-cell therapy in childhood B-cell acute lymphoblastic leukemia: a single-arm, multicenter, phase II trial. J Clin Oncol. 2023;41(9):1670\u201383. https:\/\/doi.org\/10.1200\/JCO.22.01214.","journal-title":"J Clin Oncol"},{"key":"3695_CR2","doi-asserted-by":"publisher","unstructured":".Jacobson CA, Chavez JC, Sehgal AR, et al. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2022;23(1):91\u2013103. https:\/\/doi.org\/10.1016\/S1470-2045(21)00591-X","DOI":"10.1016\/S1470-2045(21)00591-X"},{"issue":"23","key":"3695_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u201373. https:\/\/doi.org\/10.1056\/NEJMra2026131.","journal-title":"N Engl J Med"},{"key":"3695_CR4","doi-asserted-by":"publisher","unstructured":"Cohen AD, Parekh S, Santomasso BD, et al. Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.\u00a0Blood Cancer J. 2022;12(2):32. Published 2022 Feb 24. https:\/\/doi.org\/10.1038\/s41408-022-00629-1","DOI":"10.1038\/s41408-022-00629-1"},{"issue":"5","key":"3695_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbmt.2019.11.027","volume":"26","author":"Y Wang","year":"2020","unstructured":"Wang Y, Qi K, Cheng H, et al. Coagulation disorders after chimeric antigen receptor T cell therapy: analysis of 100 patients with relapsed and refractory hematologic malignancies. Biol Blood Marrow Transplant. 2020;26(5):865\u201375. https:\/\/doi.org\/10.1016\/j.bbmt.2019.11.027.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"3695_CR6","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/j.jacc.2019.10.038","volume":"74","author":"RM Alvi","year":"2019","unstructured":"Alvi RM, Frigault MJ, Fradley MG, et al. Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T). J Am Coll Cardiol. 2019;74(25):3099\u2013108. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.038.","journal-title":"J Am Coll Cardiol"},{"key":"3695_CR7","doi-asserted-by":"publisher","unstructured":"Chong EA, Ruella M, Schuster SJ. Lymphoma Program Investigators at the University of Pennsylvania. Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy. N Engl J Med. 2021;384(7):673\u2013674. https:\/\/doi.org\/10.1056\/NEJMc2030164","DOI":"10.1056\/NEJMc2030164"},{"key":"3695_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.intimp.2018.01.036","volume":"56","author":"ME Meniailo","year":"2018","unstructured":"Meniailo ME, Malashchenko VV, Shmarov VA, et al. Interleukin-8 favors pro-inflammatory activity of human monocytes\/macrophages. Int Immunopharmacol. 2018;56:217\u201321. https:\/\/doi.org\/10.1016\/j.intimp.2018.01.036.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3695_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2017-10-812495","volume":"131","author":"A Kommalapati","year":"2018","unstructured":"Kommalapati A, Tella SH, Durkin M, Go RS, Goyal G. Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018;131(2):265\u20138. https:\/\/doi.org\/10.1182\/blood-2017-10-812495.","journal-title":"Blood"},{"key":"3695_CR10","doi-asserted-by":"publisher","unstructured":"Aparicio-P\u00e9rez C, Carmona M, Benabdellah K, Herrera C. Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL. Front Immunol. 2023;14:1165870. Published 2023 Apr 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1165870","DOI":"10.3389\/fimmu.2023.1165870"},{"key":"3695_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12308-022-00519-2","volume":"15","author":"E Gauto-Mariotti","year":"2022","unstructured":"Gauto-Mariotti E, Nguyen AJ, Waters C, et al. Transdifferentiation of high-grade B-cell lymphoma with MYC and BCL2 rearrangements into histiocytic sarcoma after CAR T-cell therapy: a case report. J Hematopathol. 2022;15:229\u201337. https:\/\/doi.org\/10.1007\/s12308-022-00519-2.","journal-title":"J Hematopathol"},{"issue":"20","key":"3695_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMc1511490","volume":"378","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Solit DB, Tap WD. Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation. N Engl J Med. 2018;378(20):1945\u20137. https:\/\/doi.org\/10.1056\/NEJMc1511490.","journal-title":"N Engl J Med"},{"key":"3695_CR13","doi-asserted-by":"publisher","unstructured":"Hu B, Patel JL, Tao R, Cannon RB, Monroe M, Goyal G. Near complete response to trametinib treatment in histiocytic sarcoma harboring a somatic KRAS mutation.\u00a0J Natl Compr Canc Netw. 2022;20(6):618\u2013621. Published 2022 Mar 24. https:\/\/doi.org\/10.6004\/jnccn.2022.7001","DOI":"10.6004\/jnccn.2022.7001"},{"key":"3695_CR14","doi-asserted-by":"publisher","unstructured":"Zhao Y, Deng Y, Jiang Y, et al. Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis. Front Immunol. 2023;14:1127599. Published 2023 Mar 8. https:\/\/doi.org\/10.3389\/fimmu.2023.1127599","DOI":"10.3389\/fimmu.2023.1127599"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03695-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03695-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03695-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T06:25:51Z","timestamp":1718605551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03695-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3695"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03695-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was approved by the institutional review board of SCMC.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}